Massachusetts Financial Services Co. MA increased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 688,228 shares of the biopharmaceutical company’s stock after acquiring an additional 15,831 shares […]